A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling

Conclusion:Our findings suggest that VnP-16 is a potential therapeutic agent for treating osteoporosis that mediates its effects through dual regulation of bone remodeling.

http://link.springer.com/10.1007/s13770-022-00486-w

Source: Tissue Engineering and Regenerative Medicine - October 7, 2022 Category: Biotechnology Source Type: research